MentionFox
Home › funding signals › REGENTIS BIOMATERIALS LTD.
Form D · on the record

REGENTIS BIOMATERIALS LTD. — $6.50M Form D filing, June 2026

REGENTIS BIOMATERIALS LTD. filed a Form D with the Securities and Exchange Commission on 2026-06-25.

Get the full cited report on REGENTIS BIOMATERIALS LTD.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

See a sample report

Just raised? Share it.

REGENTIS BIOMATERIALS LTD.: Raised $6.50M, Form D filed 2026-06-25

What do you want to do with REGENTIS BIOMATERIALS LTD.?

Key facts

  • · Form D filed with the SEC · Form D
  • · Sold to date: $6.50M · Form D
  • · Total offering: $6.50M · Form D
  • · First sale: 2026-06-17 · Form D
  • · Investors already in: 22 · Form D

REGENTIS BIOMATERIALS LTD.

New Form D on file · 2026-06-25 · the record

$6.50M
raise on the record
D
filing
22
investors in
ISRAEL
based
Open the record →

What the record says

FilingForm D
Filed2026-06-25
Industry groupBiotechnology
Entity typeCorporation
Incorporated inISRAEL
BasedHERZLIYA, ISRAEL
CIK1912966
Accession0001213900-26-072125
Biotechnology · by week
This raise, $6.50M, filed week of Jun 22

Trailing twelve months. 759 filings in Biotechnology, totalled by week. The dot is this raise, $6.50M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on REGENTIS BIOMATERIALS LTD.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on REGENTIS BIOMATERIALS LTD.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on REGENTIS BIOMATERIALS LTD. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on Target: the verdict, 16 sections, 39 cited sources, dated 2026-09-28A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind REGENTIS BIOMATERIALS LTD.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for REGENTIS BIOMATERIALS LTD.. With no account yet, you sign up free and land on the result.

More on REGENTIS BIOMATERIALS LTD.

Cite this page

Permanent URL: https://mentionfox.com/funding/regentis-biomaterials-ltd-form-d-26000001
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2
REGENTIS BIOMATERIALS LTD. raised $6.50M — SEC Form D filing, June 2026. MentionFox, 2026-09-26. https://mentionfox.com/funding/regentis-biomaterials-ltd-form-d-26000001